NCT05668273 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bektas, I
, Yardimci, F., Bektas, M., & White, K. A. (2017). Psychometric properties of the Turkish version of nursing anxiety and self-confidence with clinical decision-making scale (NASC-CDM-T). Dokuz Eylül Üniversitesi Hemsirelik Fakültesi Elektronik Dergisi, 10(2), 83-92.
Gawlik, K
S., Melnyk, B.M., Teall, A.M. (Eds.), (2022), Evidence-based physical examination handbook, Springer Publishing Company, LLC
Hogan-Quigley, B
, Palm, M.L., Bickley, L.S., (2012). Bates' nursing guide to physical examination and history taking. Wolters Kluwer Health | Lippincott Williams & Wilkins.

The Effect of Simulation in the Teaching of Auscultation Skills on Patient Assessment, and Anxiety and Self-Confidence With Clinical Decision Making

Clinical trial NCT05668273 - References